P-MSCs treatment upregulates the PI3K-Akt signaling in adipose tissues and restores the Glut4 expression in the WNIN/GR-Ob (Ob-T2D) rats. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.